Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

Actelion: Delivering well on schedule

BUY-Top Picks, Fair Value CHF156 vs. CHF154 (+20%)

Published last October Wednesday 21, 2015

Temenos Group: Q3 15 results above expectations, FY15 guidance reiterated, good visibility ahead

Published last October Wednesday 21, 2015

BIC: Q3 LFL growth and normalised IFO margin below expectations

NEUTRAL, Fair Value EUR120 (-14%)

Published last October Wednesday 21, 2015

SAP: Q3 15 conference call feedback: basics right

NEUTRAL, Fair Value EUR70 vs. EUR68 (+5%)

Published last October Wednesday 21, 2015

Rémy Cointreau: Back from Cognac

BUY, Fair Value EUR72 (+19%)

Published last October Wednesday 21, 2015

Novartis: Novartis makes new inroads into immuno-oncology

BUY, Fair Value CHF110 (+24%)

Published last October Wednesday 21, 2015

Actelion: Today is a crucial day for ZS Pharma

BUY-Top Picks, Fair Value CHF156 vs. CHF154 (+20%)

Published last October Wednesday 21, 2015
Bryan, Garnier & Co GmbH advised tado° on $17.1m Equity Investment from Siemens Venture Capital, BayBG, Statkraft Ventures, and Existing Investors

Bryan, Garnier & Co GmbH advised tado° on $17.1m Equity Investment from Siemens Venture Capital, BayBG, Statkraft Ventures, and Existing Investors

Published last October Tuesday 20, 2015

ERYTech: Pfizer’s inotuzumab gets breakthrough therapy designation in ALL. Read-across for Erytech

BUY, Fair Value EUR42 (+42%)

Published last October Tuesday 20, 2015
Leading temporary work HR online management platform Pixid acquired by Keensight Capital

Leading temporary work HR online management platform Pixid acquired by Keensight Capital

Published last October Monday 19, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities